% of ETF
|ARKG||7 Sep 2021||Buy||NVTA||INVITAE CORP||261,144||0.0900|
|ARKG||7 Sep 2021||Sell||MCRB||SERES THERAPEUTICS INC||900||0.0000|
|ARKG||7 Sep 2021||Sell||DRNA||DICERNA PHARMACEUTICALS INC||152,759||0.0400|
|ARKG||7 Sep 2021||Buy||CRSP||CRISPR THERAPEUTICS AG||23,000||0.0300|
|ARKG||7 Sep 2021||Sell||CRBU||CARIBOU BIOSCIENCES INC||229,324||0.0800|
|ARKG||7 Sep 2021||Sell||CLLS||CELLECTIS SA||3,230||0.0000|
|ARKG||7 Sep 2021||Buy||ADPT||ADAPTIVE BIOTECHNOLOGIES CORP||192,885||0.0900|
|ARKG||3 Sep 2021||Buy||RPTX||REPARE THERAPEUTICS INC||43,769||0.0200|
|ARKG||3 Sep 2021||Sell||RHHBY||ROCHE HOLDING AG||225,794||0.1300|
|ARKG||3 Sep 2021||Sell||PSTI||PLURISTEM THERAPEUTICS INC||21,208||0.0000|
|ARKG||3 Sep 2021||Buy||PSNL||PERSONALIS INC||11,524||0.0000|
|ARKG||3 Sep 2021||Buy||PFE||PFIZER INC||84,604||0.0500|
|ARKG||3 Sep 2021||Buy||NVTA||INVITAE CORP||19,564||0.0100|
|ARKG||3 Sep 2021||Sell||MCRB||SERES THERAPEUTICS INC||19,400||0.0000|
|ARKG||3 Sep 2021||Buy||FATE||FATE THERAPEUTICS INC||74,850||0.0600|
|ARKG||3 Sep 2021||Sell||CLLS||CELLECTIS SA||4,834||0.0000|
|ARKG||3 Sep 2021||Buy||ADPT||ADAPTIVE BIOTECHNOLOGIES CORP||2,133||0.0000|
|ARKG||2 Sep 2021||Buy||VEEV||VEEVA SYSTEMS INC||57,616||0.2100|
|ARKG||2 Sep 2021||Sell||SEER||SEER INC||202||0.0000|
|ARKG||2 Sep 2021||Sell||RHHBY||ROCHE HOLDING AG||189,700||0.1100|
|ARKG||2 Sep 2021||Sell||PSTI||PLURISTEM THERAPEUTICS INC||20,154||0.0000|
|ARKG||2 Sep 2021||Buy||PSNL||PERSONALIS INC||21,034||0.0100|
|ARKG||2 Sep 2021||Buy||PFE||PFIZER INC||178,926||0.1000|
|ARKG||2 Sep 2021||Buy||NVTA||INVITAE CORP||17,243||0.0100|
|ARKG||2 Sep 2021||Sell||MCRB||SERES THERAPEUTICS INC||383,560||0.0300|
|ARKG||2 Sep 2021||Sell||CLLS||CELLECTIS SA||30,229||0.0100|
|ARKG||1 Sep 2021||Sell||SEER||SEER INC||3,702||0.0017|
|ARKG||1 Sep 2021||Buy||RPTX||REPARE THERAPEUTICS INC||3,200||0.0013|
|ARKG||1 Sep 2021||Sell||RHHBY||ROCHE HOLDING AG||426,800||0.2511|
|ARKG||1 Sep 2021||Sell||PSTI||PLURISTEM THERAPEUTICS INC||19,873||0.0007|
|ARKG||1 Sep 2021||Buy||PSNL||PERSONALIS INC||3,781||0.0010|
|ARKG||1 Sep 2021||Buy||PFE||PFIZER INC||382,231||0.2051|
|ARKG||1 Sep 2021||Buy||NVTA||INVITAE CORP||12,514||0.0044|
|ARKG||1 Sep 2021||Sell||NVS||NOVARTIS AG||32,322||0.0352|
|ARKG||1 Sep 2021||Sell||MCRB||SERES THERAPEUTICS INC||682,519||0.0517|
|ARKG||1 Sep 2021||Sell||CLLS||CELLECTIS SA||21,200||0.0037|
|ARKG||1 Sep 2021||Buy||ADPT||ADAPTIVE BIOTECHNOLOGIES CORP||800||0.0003|
|ARKG||31 Aug 2021||Buy||RPTX||REPARE THERAPEUTICS INC||52,716||0.0210|
|ARKG||31 Aug 2021||Sell||RHHBY||ROCHE HOLDING AG||229,100||0.1372|
|ARKG||31 Aug 2021||Sell||PSTI||PLURISTEM THERAPEUTICS INC||13,833||0.0005|
|ARKG||31 Aug 2021||Buy||PSNL||PERSONALIS INC||19,246||0.0048|
|ARKG||31 Aug 2021||Buy||PFE||PFIZER INC||86,248||0.0480|
|ARKG||31 Aug 2021||Buy||NVTA||INVITAE CORP||20,319||0.0070|
|ARKG||31 Aug 2021||Sell||NVS||NOVARTIS AG||142,994||0.1572|
|ARKG||31 Aug 2021||Buy||FATE||FATE THERAPEUTICS INC||62,266||0.0534|
|ARKG||31 Aug 2021||Sell||CLLS||CELLECTIS SA||20,248||0.0035|
|ARKG||31 Aug 2021||Buy||ADPT||ADAPTIVE BIOTECHNOLOGIES CORP||5,886||0.0025|
|ARKG||30 Aug 2021||Buy||RPTX||REPARE THERAPEUTICS INC||816||0.0003|
|ARKG||30 Aug 2021||Sell||RHHBY||ROCHE HOLDING AG||78,900||0.0467|
|ARKG||30 Aug 2021||Buy||QSI||QUANTUM-SI INC||163,652||0.0185|
|ARKG||30 Aug 2021||Sell||PSTI||PLURISTEM THERAPEUTICS INC||10,518||0.0004|
|ARKG||30 Aug 2021||Buy||PSNL||PERSONALIS INC||34,599||0.0086|
|ARKG||30 Aug 2021||Buy||PFE||PFIZER INC||91,400||0.0504|
|ARKG||30 Aug 2021||Buy||NVTA||INVITAE CORP||113,734||0.0392|
|ARKG||30 Aug 2021||Buy||DYNS||DYNAMICS SPECIAL PURPOSE CORP||240,000||0.0285|
|ARKG||30 Aug 2021||Sell||CLLS||CELLECTIS SA||7,300||0.0012|
|ARKG||30 Aug 2021||Buy||ADPT||ADAPTIVE BIOTECHNOLOGIES CORP||20,540||0.0088|
|ARKG||27 Aug 2021||Buy||RPTX||REPARE THERAPEUTICS INC||7,501||0.0030|
|ARKG||27 Aug 2021||Sell||RHHBY||ROCHE HOLDING AG||202,400||0.1236|
|ARKG||27 Aug 2021||Buy||QSI||QUANTUM-SI INC||1,818||0.0002|
|ARKG||27 Aug 2021||Sell||PSTI||PLURISTEM THERAPEUTICS INC||36,393||0.0013|
|ARKG||27 Aug 2021||Buy||PSNL||PERSONALIS INC||5,444||0.0013|
|ARKG||27 Aug 2021||Buy||PFE||PFIZER INC||351,289||0.2019|
|ARKG||27 Aug 2021||Sell||MCRB||SERES THERAPEUTICS INC||707,095||0.0539|
|ARKG||27 Aug 2021||Buy||FATE||FATE THERAPEUTICS INC||57,841||0.0509|
|ARKG||27 Aug 2021||Buy||DYNS||DYNAMICS SPECIAL PURPOSE CORP||49,500||0.0060|
|ARKG||27 Aug 2021||Sell||CLLS||CELLECTIS SA||4,911||0.0009|
|ARKG||27 Aug 2021||Sell||BMY||BRISTOL-MYERS SQUIBB CO||90,757||0.0741|
|ARKG||27 Aug 2021||Buy||ADPT||ADAPTIVE BIOTECHNOLOGIES CORP||1,000||0.0004|
|ARKG||26 Aug 2021||Sell||SEER||SEER INC||20,000||0.0089|
|ARKG||26 Aug 2021||Buy||RPTX||REPARE THERAPEUTICS INC||2,468||0.0010|
|ARKG||26 Aug 2021||Sell||RHHBY||ROCHE HOLDING AG||32,600||0.0196|
|ARKG||26 Aug 2021||Buy||QSI||QUANTUM-SI INC||34,201||0.0037|
|ARKG||26 Aug 2021||Sell||PSTI||PLURISTEM THERAPEUTICS INC||15,505||0.0006|
|ARKG||26 Aug 2021||Buy||PSNL||PERSONALIS INC||40,468||0.0094|
|ARKG||26 Aug 2021||Buy||PFE||PFIZER INC||173,579||0.1001|
|ARKG||26 Aug 2021||Sell||MCRB||SERES THERAPEUTICS INC||400||0.0000|
|ARKG||26 Aug 2021||Buy||MASS||908 DEVICES INC||25,000||0.0101|
|ARKG||26 Aug 2021||Buy||DYNS||DYNAMICS SPECIAL PURPOSE CORP||1,696||0.0002|
|ARKG||26 Aug 2021||Buy||CMIIU||CM LIFE SCIENCES II INC||25,000||0.0032|
|ARKG||26 Aug 2021||Sell||BMY||BRISTOL-MYERS SQUIBB CO||29,000||0.0236|
|ARKG||26 Aug 2021||Buy||BEAM||BEAM THERAPEUTICS INC||17,033||0.0207|
|ARKG||26 Aug 2021||Buy||ADPT||ADAPTIVE BIOTECHNOLOGIES CORP||62,252||0.0254|
|ARKG||25 Aug 2021||Sell||SEER||SEER INC||152,557||0.0649|
|ARKG||25 Aug 2021||Sell||RHHBY||ROCHE HOLDING AG||66,000||0.0394|
|ARKG||25 Aug 2021||Buy||QSI||QUANTUM-SI INC||117,584||0.0128|
|ARKG||25 Aug 2021||Sell||PSTI||PLURISTEM THERAPEUTICS INC||16,223||0.0006|
|ARKG||25 Aug 2021||Buy||PSNL||PERSONALIS INC||43,612||0.0103|
|ARKG||25 Aug 2021||Buy||PFE||PFIZER INC||170,809||0.0987|
|ARKG||25 Aug 2021||Buy||MASS||908 DEVICES INC||11,300||0.0047|
|ARKG||25 Aug 2021||Buy||DYNS||DYNAMICS SPECIAL PURPOSE CORP||3||0.0000|
|ARKG||25 Aug 2021||Buy||CMIIU||CM LIFE SCIENCES II INC||18,100||0.0023|
|ARKG||25 Aug 2021||Sell||BMY||BRISTOL-MYERS SQUIBB CO||114,400||0.0937|
|ARKG||25 Aug 2021||Buy||ADPT||ADAPTIVE BIOTECHNOLOGIES CORP||30,596||0.0126|
|ARKG||24 Aug 2021||Sell||SEER||SEER INC||82,789||0.0358|
|ARKG||24 Aug 2021||Buy||RPTX||REPARE THERAPEUTICS INC||229||0.0001|
|ARKG||24 Aug 2021||Sell||RHHBY||ROCHE HOLDING AG||226,200||0.1389|
|ARKG||24 Aug 2021||Buy||QSI||QUANTUM-SI INC||90,017||0.0095|
|ARKG||24 Aug 2021||Sell||PSTI||PLURISTEM THERAPEUTICS INC||48,386||0.0018|
|ARKG||24 Aug 2021||Buy||PSNL||PERSONALIS INC||4,500||0.0010|
Even while other actively managed funds and fund managers battled to recover from the COVID-19-induced slowdown, Cathie Wood's Ark Invest had a spectacular year in 2020. Wood was dubbed the "Midas Touch" after her fund's flagship ARK Innovation ETF ARKK +0.77% (Get Free Alerts for ARKK) returned a whopping 153 percent, outperforming the S& P 500 Index's 16.3 percent gain.
Ark Experiences a Post-COVID-19 Complication: By 2021, Ark's performance had become more mixed. The Ark Innovation ETF dropped 3.7 percent in the first quarter before rebounding with a 9 percent gain in the second.
According to Ark's third-quarter performance report, all of its actively managed funds and its two self-indexed ETFs underperformed the market.
The performance of each Ark ETF in the third quarter is as follows:
ETFs that are actively traded
ETF: Ark Innovation: (-15.5 percent )
The Ark Autonomous Technology & Robotics ETF (ARKQ) is an exchange-traded fund that invests in autonomous technology and robotics (-9.5 percent )
The Ark Next Generation Internet ETF (ARKW) is an exchange-traded fund that invests in the next generation of the internet (-9.9 percent )
ETF for the Ark Genomic Revolution (ARKG): (-19.3 percent )
ARK Fintech Innovation ETF ARKF +0.06%: ARK Fintech Innovation ETF ARKF +0.06%: ARK Fintech Innovation ETF ARK (-8.7 percent )
ARK Space Exploration & Innovation ETF (ARKX): Ark ETF Trust: (-6.6 percent )
ETFs that track indices
The ETF for 3D Printing (PRNT): (-10 percent )
The Ark Israel Innovation Technology ETF (IZRL) is a mutual fund that invests in Israel's innovative technology (-8.3 percent )
When compared to the more significant market performance, the low showing is exemplified. The S& P 500 Index rose 2.5 percent in the third quarter, while the Nasdaq Composite Index rose 5.1 percent.
Consumer and investor confidence is being harmed by macro headwinds, according to Wood's quarterly report. Fears of an economic slowdown arose due to a spike in the delta strain of the coronavirus, supply chain difficulties, and a Chinese government crackdown, she noted.
Ark feels that inflation fears are exaggerated and that the chances of deflation are more plausible.
Will Bitcoin Be Banned In The United States Like Gold Was? Cathie Wood and Ark Invest weigh in.
Tesla Aids In Weakness Mitigation: Wood is a self-proclaimed Tesla, Inc. TSLA +3.26 percent bull. With over 10% stakes in each, Tesla is part of the ARK Innovation ETF, the Ark Innovation ETF, and the Ark Innovation ETF.
In the third quarter, the electric vehicle behemoth topped the list of contributors to the returns of each of these ETFs.
Ark Invest sold approximately $605 million of Tesla stock in September alone, taking advantage of the EV maker's third-quarter rally.
Tesla's sales have continued far into October.
Energy and financial services are the most likely to be disrupted by innovation. The power and financial services sectors have benefited the most from the shift toward cyclical in the last nine to 12 months, according to Ark. These two industries, according to the firm, will be the most disrupted by innovation during the next five years.
"Autonomous electric vehicles and digital wallets, including cryptocurrencies and the decentralized financial services (DeFi) associated more broadly with blockchain technologies, will, in ARK's opinion, significantly disrupt and disintermediate both Energy and Financial Services over the next five years."
According to Business Insider, Ark Invest founder and CEO Cathie Wood did not invest in the ProShares Bitcoin Strategy exchange-traded fund (ETF) on its first day.
Wood had this to say regarding the ETF's debut:
"We did not [invest]," says the narrator. We're taking a close look at this [...] there are specific tax implications we'd like to learn more about in terms of contango versus more traditional backwardation."
When the future price is greater than the current price, the ETF is in contango. In a negative trend, backwardation occurs when the forward price of a futures contract is lower than the spot price.
In June, wood's Ark Invest teamed up with 21 Shares to file for its Bitcoin (BTC) ETF. When it comes to investing in cryptocurrencies, she is also no stranger to the stock market.
Ark Investment Management, one of her funds, has been permitted to invest in Canada's Bitcoin ETF, the Ark Next Generation ETF. Grayscale Bitcoin Trust (GBTC) has 8.3 million shares, with Bitcoin and Ether (ETH) accounting for a significant portion of Ark Invest's portfolio.
Ark Invest also added Coinbase stock to three of its ETFs in the spring, including the Ark Innovation ETF (ARKK), the Ark Next Generation Internet ETF (ARKW), and the Ark Fintech Innovation ETF (ARKF).
Wood stated that she is on the lookout for the next FAANG investment that will benefit her investors. FAANG is an abbreviation for the five largest American technology companies: Facebook, Amazon, Apple, Netflix, and Google. Jim Cramer first invented the phrase "FAANG" in 2013.
On its first day of trading, the Bitcoin Strategy ETF recorded the highest natural volume of any ETF and the second-highest overall volume.
Ark Investment Management said on Wednesday that it is permanently closing its New York office and relocating to St. Petersburg, Florida.
In 2020, Wood's flagship Ark Innovation exchange-traded fund soared over 150 percent, making her a Wall Street sensation.
Wood is unique in that she focuses solely on the technology industry. So it's probably unsurprising that she's quitting Wall Street.
Ark expects the move to "advance its business as it scales and continues to alter the asset management market," as well as "improve collaboration between and across the communities focused on innovation," according to the company.
"Ark isn't your typical Wall Street asset management firm, and we're excited to continue to break the mold by relocating to St. Petersburg, a city that values technology, research, and creativity," Wood added.
Jana Haines, Ark's strategy chief, said the area's "vibrant and diversified talent base" and the success of public-private partnerships centered on innovation encouraged the company.
This year hasn't been as good to Wood as the previous one. Despite a booming tech market, with the Nasdaq up more than 14 percent so far in 2021, the Innovation ETF is down 3.5 percent coming into the fourth quarter.